期刊文献+

微量元素锌、铬、钒与糖尿病 被引量:18

下载PDF
导出
摘要 糖尿病是一种常见的以慢性高血糖为主要特征的内分泌代谢疾病。锌、铬、钒作为人体必需或可能必需微量元素,与糖尿病之间具有高度相关性:锌与胰岛素的合成、分泌及生物活性密切相关;铬作为葡萄糖耐量因子的组分,是胰岛素发挥降糖作用必需的元素;钒调节糖代谢中的诸多关键酶发挥类胰岛素样活性。此外,它们还可改善蛋白质、脂肪代谢紊乱,协同发挥降糖作用。维持体内微量元素平衡在糖尿病的发生、发展、预防、治疗等方面处于不可忽略的地位,而低毒、高效的微量元素配合物的研发将为糖尿病的治疗提供有益补充。
作者 高丽辉 李玲
出处 《国外医学(卫生学分册)》 2007年第2期106-110,共5页 Foreign Medical Sciences(Section of Hygiene)
基金 国家自然科学基金(30260118) 云南省自然科学基金(2002C0019R)
  • 相关文献

参考文献29

  • 1WILD S, ROGLIC G, GREEN A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030[J]. Diabet Care,2004,27(5) : 1054-1073.
  • 2MACALL K A, HUANG C, FIERKE C A. Function and mechanism of zinc metalloenzymes [ J ]. J Nutr, 2000, 130(5 Suppl) : 1437S-1446S.
  • 3DUNN M F. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer-a review [ J ].Biometals, 2005,18 (4) : 295-303.
  • 4FAURE P. Protective effects of antioxidant micronutrients (vitamin E, zinc and selenium) in type 2 diabetes mellitus[J]. Clin Chem Lab Med,2003,41 (8):995-998.
  • 5YOSHIKAWA Y, KONDO M, SAKURAI H. A family of insulinomimetic zinc( Ⅱ ) complexes of amino ligands with Zn(Nn) (n = 3 and 4) coordination modes[J]. J Inorg Biochem ,2005,99(7) : 1497-1503.
  • 6ADACHI Y, YOSHIDA J, KODERA Y. A new insulinmimetic bis ( allixinato ) zinc ( Ⅱ ) complex: structureactivity relationship of zinc ( Ⅱ ) complexes [ J ]. J Biol Inorg Chem,2004,9(7) :115-193.
  • 7AL-MAROOF R A, Al-SHARBATTI S S. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics[J]. Saudi Med J, 2006,27(3) :344-350.
  • 8PARTIDA-HERNANDEZ G, ARREOLA F, FENTON B,et al. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients [ J ]. Biomed Pharmacother,2006, 60(4) :161-168.
  • 9吴蕴棠,孙忠,车素萍,王夏,王永明,郭刚.铬对糖尿病大鼠骨骼肌组织基因表达的调控作用[J].卫生研究,2005,34(2):184-187. 被引量:10
  • 10VINCENT J B. Mechanisms of chromium action: lowmolecular-weight chromium-binding substance [ J ]. J Am Coll Nutr, 1999,18(1) :6-12.

二级参考文献15

  • 1[1]Golubev-MA.[Comparative characteristics of vanadium-containing compounds,possessing insulin-like effects].Vopr-Med-Khim,2000,46(2):155
  • 2[2]Karasik A.Use of animal models in the study of diabetes.Jolin's Diabetes Mellitus,1994,134:507
  • 3[3]Yale J-F,Daniell Lachance,A.Paul Bevan,et al.Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats.Diabetes,1995,44(11):1274
  • 4[4]Madsen-KL,D.Ariano,R.N.Fedorak,et al.Vanadate treatment rapidly improves glucose transport and activates 6-phosphofructo-1-kinase in diabetic rat intestine.Diabetologia,1995,38(4):403
  • 5[5]Reul-BA,Sean S.Amin,Jean-Pierre,et al.Effects of vanadium complexes with organic ligands on glucose metabolism:a comparison study in diabetic rats.Br J Pharmacol,1999,126(2):467
  • 6[6]Goldfine-AB,Patti-ME,Zuberi-L,et al.Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus:in vivo and in vitro studies.Metabolism,2000,49(3):400
  • 7[7]Gupta-D,Raju-J,Baquer-NZ.Modulation of some gluconeogenic enzyme activities in diabetic rat liver and kidney:effect of antidiabetic compounds.Indian J Exp Biol,1999,37(2):196
  • 8[8]Cam-MC,W.M.Li,J.H.McNeill.Partial preservation of pancreatic beta-cells by vanadium:evidence for long-term amelioration of diabetes.Metabolism,1997,46(7):769
  • 9[9]Tsuji-A,Sakurai-H.Vanadyl ion suppresses nitric oxide production from peritoneal macrophages of streptozotocin-induced diabetic mice.Biochem Biophys Res Commun,1996,226(2):506
  • 10Mertz W. Chromium in human nutrition: a review. J Nutr, 1993,123 (4):626-633

共引文献12

同被引文献203

引证文献18

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部